Get started
Author

Jane Y. Edwards

Naringenin Prevents Dyslipidemia, Apolipoprotein B Overproduction, and Hyperinsulinemia in LDL Receptor–Null Mice With Diet-Induced Insulin Resistance
2009 · Erin E. Mulvihill, Emma M. Allister, et al. · Diabetes · 298
PDF
Nobiletin Attenuates VLDL Overproduction, Dyslipidemia, and Atherosclerosis in Mice With Diet-Induced Insulin Resistance
2011 · Erin E. Mulvihill, Julia M. Assini, et al. · Diabetes · 202
PDF
Naringenin prevents cholesterol-induced systemic inflammation, metabolic dysregulation, and atherosclerosis in Ldlr mice
2012 · Julia M. Assini, Erin E. Mulvihill, et al. · Journal of Lipid Research · 140
PDF
Intervention with citrus flavonoids reverses obesity and improves metabolic syndrome and atherosclerosis in obese Ldlr−/− mice
2018 · Amy C. Burke, Brian G. Sutherland, et al. · Journal of Lipid Research · 129
PDF
Regulation of Macrophage Cholesterol Efflux through Hydroxymethylglutaryl-CoA Reductase Inhibition
2005 · Carmen A. Argmann, Jane Y. Edwards, et al. · Journal of Biological Chemistry · 129
PDF
Soya phytoestrogens, genistein and daidzein, decrease apolipoprotein B secretion from HepG2 cells through multiple mechanisms
2002 · Nica M. BORRADAILE, Linda E. de DREU, et al. · Biochemical Journal · 123
Inhibition of Microsomal Triglyceride Transfer Protein Expression and Apolipoprotein B100 Secretion by the Citrus Flavonoid Naringenin and by Insulin Involves Activation of the Mitogen-Activated Protein Kinase Pathway in Hepatocytes
2005 · Emma M. Allister, Nica M. Borradaile, et al. · Diabetes · 116
PDF
The molecular mechanisms underlying the reduction of LDL apoB-100 by ezetimibe plus simvastatin
2006 · Dawn E. Telford, Brian G. Sutherland, et al. · Journal of Lipid Research · 110
PDF
Selective Up-regulation of LXR-regulated Genes ABCA1, ABCG1, and APOE in Macrophages through Increased Endogenous Synthesis of 24(S),25-Epoxycholesterol
2006 · Michael M. Beyea, Claire L. Heslop, et al. · Journal of Biological Chemistry · 105
Prevention of Diet-Induced Metabolic Dysregulation, Inflammation, and Atherosclerosis in Ldlr −/− Mice by Treatment With the ATP-Citrate Lyase Inhibitor Bempedoic Acid
2017 · Joshua P. Samsoondar, Amy C. Burke, et al. · Arteriosclerosis Thrombosis and Vascular Biology · 96
Enhanced Synthesis of the Oxysterol 24( S ),25-Epoxycholesterol in Macrophages by Inhibitors of 2,3-Oxidosqualene:Lanosterol Cyclase
2003 · Andrea H. Rowe, Carmen A. Argmann, et al. · Circulation Research · 89
Transforming Growth Factor-β1 Inhibits Macrophage Cholesteryl Ester Accumulation Induced by Native and Oxidized VLDL Remnants
2001 · Carmen A. Argmann, Caroline H. Van Den Diepstraten, et al. · Arteriosclerosis Thrombosis and Vascular Biology · 81
PPARδ activation attenuates hepatic steatosis in Ldlr mice by enhanced fat oxidation, reduced lipogenesis, and improved insulin sensitivity
2014 · Lazar A. Bojic, Dawn E. Telford, et al. · Journal of Lipid Research · 75
PDF
Inhibition of the Apical Sodium-Dependent Bile Acid Transporter Reduces LDL Cholesterol and ApoB by Enhanced Plasma Clearance of LDL ApoB
2002 · Murray W. Huff, Dawn E. Telford, et al. · Arteriosclerosis Thrombosis and Vascular Biology · 59
Peroxisome Proliferator–Activated Receptor δ Agonist GW1516 Attenuates Diet-Induced Aortic Inflammation, Insulin Resistance, and Atherosclerosis in Low-Density Lipoprotein Receptor Knockout Mice
2013 · Lazar A. Bojic, Amy C. Burke, et al. · Arteriosclerosis Thrombosis and Vascular Biology · 52
PDF
Activation of Peroxisome Proliferator-Activated Receptor δ Inhibits Human Macrophage Foam Cell Formation and the Inflammatory Response Induced by Very Low-Density Lipoprotein
2012 · Lazar A. Bojic, Cynthia G. Sawyez, et al. · Arteriosclerosis Thrombosis and Vascular Biology · 51
Inhibition of apoB secretion from HepG2 cells by insulin is amplified by naringenin, independent of the insulin receptor
2008 · Emma M. Allister, Erin E. Mulvihill, et al. · Journal of Lipid Research · 50
PDF
Bempedoic Acid Lowers Low-Density Lipoprotein Cholesterol and Attenuates Atherosclerosis in Low-Density Lipoprotein Receptor–Deficient ( LDLR +/− and LDLR −/− ) Yucatan Miniature Pigs
2018 · Amy C. Burke, Dawn E. Telford, et al. · Arteriosclerosis Thrombosis and Vascular Biology · 44
Naringenin Supplementation to a Chow Diet Enhances Energy Expenditure and Fatty Acid Oxidation, and Reduces Adiposity in Lean, Pair‐Fed Ldlr−/− Mice
2018 · Amy C. Burke, Dawn E. Telford, et al. · Molecular Nutrition & Food Research · 42
Naringenin enhances the regression of atherosclerosis induced by a chow diet in Ldlr mice
2019 · Amy C. Burke, Brian G. Sutherland, et al. · Atherosclerosis · 35
Inhibition of both the apical sodium-dependent bile acid transporter and HMG-CoA reductase markedly enhances the clearance of LDL apoB
2003 · Dawn E. Telford, Jane Y. Edwards, et al. · Journal of Lipid Research · 30
PDF
The Oxysterol 24 (S) ,25‐Epoxycholesterol Attenuates Human Smooth Muscle–Derived Foam Cell Formation Via Reduced Low‐Density Lipoprotein Uptake and Enhanced Cholesterol Efflux
2012 · Michael M. Beyea, Samantha Reaume, et al. · Journal of the American Heart Association · 28
PDF
A Novel Inhibitor of Oxidosqualene:Lanosterol Cyclase Inhibits Very Low–Density Lipoprotein Apolipoprotein B100 (ApoB100) Production and Enhances Low-Density Lipoprotein ApoB100 Catabolism Through Marked Reduction in Hepatic Cholesterol Content
2005 · Dawn E. Telford, Sara M. Lipson, et al. · Arteriosclerosis Thrombosis and Vascular Biology · 21
Ankyrin G overexpression in Hutchinson-Gilford progeria syndrome fibroblasts identified through biological filtering of expression profiles
2006 · Jian Wang, John F. Robinson, et al. · Journal of Human Genetics · 16
The role of the immunoglobulin heavy chain in human anti‐dna antibody binding specificity
1995 · Ahmoud Mahmoudi, Gregory A. Denomme, et al. · Arthritis & Rheumatism · 11
Works count: 44
Citation count: 2,141
H-index: 22
I10-index: 25
Year
Topic
Type